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Recently we noted (Hollak, C. E. M., van Weely, S., van 
Oers, M. H. J., and Aerts, J. M. F. G. (1994) J. Clin. Invest. 
93, 1288-1292) that the clinical manifestation ofGaucher 
disease is associated with a several hundred-fold in-
crease in chitotriosidase activity in plasma. We report 
on the purification and characterization of the protein. 
Two major isoforms of chitotriosidase with isoelectric 
points of 7.2 and 8.0 and molecular masses of 50 and 39 
kDa, respectively, were ,purified from the spleen of a 
Gaucher patient. TheN-terminal amino acid sequence of 
the two forms proved to be identical. An antiserum 
raised against the purified 39-kDa chitotriosidase pre-
cipitated all isozymes. Chitotriosidase activity was ear-
lier found to be completely absent in some individuals. 
These findings in combination suggest that a single gene 
may encode the different isoforms of chitotriosidase. 
Both the N-terminal sequence and an internal se-
quence chitotriosidase proved to be homologous to se-
quences in proteins that are members of the chitinase 
family (Hakala, B. E., White, C., and Recklies, A. D. (1993) 
J. Biol. Chem. 268, 25803-25810). The human chitotriosi-
dase described here showed chitinolytic activity toward 
artificial substrates as well as chitin and may therefore 
be considered to be a chitinase. 
Gaucher disease is a recessively inherited lysosomal storage 
disorder in which the activity of the enzyme glucocerebrosidase 
is markedly decreased. This results in accumulation of the 
glycolipid glucosylceramide in the lysosomes of macrophages 
(1). Recently, enzyme-replacement therapy has been success-
fully applied by infusing purified placental glucocerebrosidase, 
which has been modified so as to target the enzyme to mac-
rophages (2). The clinical manifestation of Gaucher disease is 
generally accompanied by increased plasma levels of certain 
enzyme activities, including acid phosphatase 5B (3), angioten-
sin-converting enzyme (4, 5), lysosomal hydrolases (6, 7), and 
lysozyme (5, 8). For instance, there is an approximately 10-fold 
increase in the activity of acid phosphatase 5B in plasma of 
Gaucher patients compared with that of controls (see e.g. Ref. 
9); the elevations in the activity of other enzymes are much less 
pronounced. 
Chitotriosidase activity was found to be on average more 
than 600 times increased in plasma of Gaucher patients corn-
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pared with controls (9). Such a marked elevation has, so far, 
been observed only in samples from Gaucher patients and not 
in plasma from patients with other pathological conditions. 
Moreover, successful therapeutic intervention in Gaucher dis-
ease proved to be accompanied by a rapid and marked reduc-
tion in the chitotriosidase levels in plasma (9). In our previous 
study it was observed that chitotriosidase is a secretory protein 
of cultured macrophages (9). A small amount of enzyme is also 
found intracellularly, possibly in lysosomes. The enzyme does 
not show the characteristic acid pH optimum of lysosomal 
enzymes but has very similar activity in the pH range 3-8. 
Human chitotriosidase had not been purified so far, and little 
is known about the nature and function of the enzyme. Fur-
thermore, the relationship between the several hundred-fold 
increased plasma levels of chitotriosidase and the pathophysi-
ology of Gaucher disease is unclear. Here, we report on the 
purification of chitotriosidase from Gaucher spleen and de-
scribe a number of characteristics of the enzyme. 
MATERIALS AND METHODS 
Enzyme Assays-Chitotriosidase and chitobiosidase activities were 
routinely determined with the fluorogenic substrates 4MU1-chitobiose 
(Sigma, 4-methylumbelliferyl {3-D-N ,N' -diacetylchitobiose) and 4MU-
chitotriose (Sigma, 4-methylumbelliferyl {3-D-N ,N' ,N"-triacetylchitotri-
ose). Substrate mixtures contained 0.027 mM substrate and 1 mg/ml 
bovine serum albumin in Mcllvain buffer (100 mM citric acid, 200 mM 
sodium phosphate), pH 5.2. Assays were performed as described 
previously (9). 
The two PNP substrates (Sigma, p-nitrophenyl {3-D-N ,N' -diacetylchi-
tobiose and p-nitrophenyl {3-D-N ,N' ,N''-triacetylchitotriose) were used 
in Mcllvain buffer (pH 5.2) at a concentration of 370 and 270 tJ.M, 
respectively. Assays (final volume, 100 tJ.ll were stopped with 50 tJ.l of 3 
M glycine-NaOH buffer (pH 10.6). The p-nitrophenyl formed was deter-
mined spectrophotometrically at 405 nm. 
Chitinase activity was determined using chitin azure (Sigma), which 
was suspended in Mcllvain buffer (pH 5.2). The final concentration of 
chitin azure particles was 10 mg/ml. Degradation was monitored by 
spectrophotometric detection at 550 nm of soluble azure after centrifu-
gation (10). Chitinase from Serratia marcescens (Sigma) was used as a 
control. 
Lysozyme activity was determined according to Morsky (11) by meas-
uring the decrease in absorbance at 450 nm of a Micrococcus lysodeik-
ticus suspension (Sigma, 0.26 mg/ml) in Mcllvain buffer (pH 5.2). Ly-
sozyme from human milk (Sigma) was used as a control. 
Purification of Chitotriosidase-Detergent-free spleen extract was 
prepared by homogenization of Gaucher type I spleen in 4 volumes of 
water, using an Ultra-turrax and centrifugation for 20 min at 15,000 X 
g. The pH of the supernatant was adjusted to 8.5 using 1 M Tris buffer 
(final concentration, 25 mM), and the supernatant was applied to a 
polybuffer exchange column (PBE 94, Pharmacia Biotech Inc.); the 
column was equilibrated and eluted with 25 mM Tris buffer (pH 8.5). 
Breakthrough fractions with highest chitotriosidase activity were 
pooled and concentrated by Amicon PM10 ultrafiltration. This pool was 
1 The abbreviations used are: 4MU, 4-methylumbelliferyl; PNP, p-
nitrophenyl; PBE, polybuffer exchanger; PAGE, polyacrylamide gel 
electrophoresis; IEF, isoelectric focusing. 
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applied to a Sephadex G-100 (Pharmacia) column and eluted with 25 
mM Tris buffer (pH 8.0). Fractions were collected and peak fractions 
containing enzyme activity were pooled and concentrated again. As a 
fina l step in the isolation procedure preparative isoelectric focusing was 
performed. 
Protein concentrations were determined according to the method of 
Lowry et al. (12), using bovine serum albumin as standard. 
Isoelectric Focusing-Preparative flat-bed isoelectric focusing was 
performed using Ultrodex (Pharmacia) containing 0.5% (v/v) Triton 
X-100 and 0.1% w/v ampholytes (Ser valyte 4-9, Serva). Focusing was 
performed overnight at 10 oc at 400 V, using an LKB 2117 Multiphor 
apparatus as described by the manufacturer. The gel was fractionated 
and extracted with water, after which the chitotriosidase activity and 
pH of the fractions were determined. 
Chitotriosidase Fragmentation by Proteolytic Digestion-Purified 
chitotriosidase was denatured by boiling in 1% J3-mercaptoethanol and 
0.5% SDS. Digestion was done with trypsin (Boehringer Mannheim) 
(chitotriosidase:trypsin, w/w, was about 100:1) at room temperature for 
5 min and stopped by boiling in SDS-PAGE sample buffer. 
SDS-PAGE-SDS-PAGE was performed on a Pharmacia Phast-gel 
system, according to the manufacturer's instructions, using 12.5% (w/v) 
acrylamide gels. After electrophoretic separation the gels were silver-
stained. For the separation of proteins prior to sequencing, 10% SOS-
PAGE gels were used according to the method ofLaemmli (13). Protein 
digests were separated on 12% gels . 
Protein Sequencing-Protein samples were separated on SDS-PAGE 
and blotted to polyvinylidene difluoride membrane (Bio-Rad) using a 
blotting buffer containing 50 mM Tris, 50 mM borate, 20% (v/v) metha-
nol , and 0.02% (w/v) SDS (pH 8.1-8.5). Blots were stained with 1% (w/v) 
Coomassie Brilliant Blue (R-250) in 50% v/v methanol , destained with 
10% acetic acid in 50% methanol , and dried. Protein bands were applied 
to a Beckman/Porton LF 3000 protein sequencer coupled to a Beckman 
System Gold phenylthiohydantoin analyzer. The sequences obtained 
were compared with those present in the EMBL data bank. 
Determination of Native Molecular Weight by Gel Filtration-Seph-
adex G-100 (Pharmacia) gel fi ltration was used to determine the native 
molecular weight of chitotriosidase. A column was calibrated using the 
following proteins as standards: cytochrome c (12.4 kDa), carbonic 
anhydrase (29 kDa), ovalbumin (43 kDa), bovine serum albumin (67 
kDa), and alcohol dehydrogenase (150 kDa). 
Immunoprecipitation-Immunoprecipitation of chitotriosidase with 
immobilized antibodies was performed as described in Ref. 9. 
RESULTS 
Purification of Chitotriosidases-Chitotriosidase activity 
was found to be about 50-fold increased in spleen of a type I 
Gaucher patient as compared with spleen from a control sub-
ject. The enzyme activity was completely recovered in the su-
pernatant of a detergent-free extract that was used as starting 
material for the isolation of chitotriosidase. The extract was 
applied on a polybuffer exchange chromatofocusing column 
(PBE 94), equilibrated to pH 8.5. The chitotriosidase activity 
was not bound and only slightly retained by the column, in 
contrast to total protein. The fractions enriched in enzyme 
activity were pooled and, after concentration via ultrafiltration, 
subjected to Sephadex G-100 gel filtration . Fractions contain-
ing chitotriosidase activity were pooled, concentrated, and sub-
jected to isoelectric focusing. Measurement of chitotriosidase 
activity in the fractionated gel showed the presence of two 
distinct forms of chitotriosidase with apparent pis of 7.2 and 
8.0, respectively (not shown). Analysis by SDS-PAGE and sil-
ver staining showed that the pi 8.0 fraction contained a protein 
with an apparent molecular mass of 39 kDa (Fig. 1, lane 4). 
Depending on the fractionation of the gel, minor amounts of 
other proteins were sometimes noted in chitotriosidase-con-
taining fractions in the pi range 7.9-8.2. However, chitotrio-
sidase activity in such fractions always correlated with the 
concentration of the 39-kDa protein only. The chitotriosidase-
containing fractions with pi around 7.2 contained several pro-
teins with apparent molecular masses of 50, 42, 25, and 18 kDa 
(Fig. 1, lane 5). 
The native molecular masses of the pi 8.0 and 7.2 chitotrio-
sidases were 29 and 37 kDa, respectively, on a calibrated Seph-
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FIG. 1. Analysis of protein constituents of fractions of a typical 
chitotriosidase purification procedure. Proteins were separated on 
12.5% SDS-PAGE gel and visualized by silver staining. Molecular mass 
standards are indicated (kDa). Lane 1, spleen extract; lane 2, pool of 
PBE column; lane 3, pool of Sephadex G-100 column; lane 4, IEF 
fraction with pH of 8.0; lane 5, IEF fraction with pH of 7.2. The 39-kDa 
isoform of chitotriosidase is indicated by an arrow and the 50-kDa 
isoform by an arrowhead. 
adex G-100 column (not shown). 
Table I gives the results overview of a typical isolation. The 
amount of 39-kDa chitotriosidase in the final pi 8.0 fraction 
was determined by silver staining and comparison with known 
amounts of bovine serum albumin. The isolation procedure 
resulted in a more than 3600-fold purification of the 39-kDa (pi 
8.0) chitotriosidase from an extract of a spleen from a type I 
Gaucher patient. Four independent isolations gave comparable 
results. 
Amino Acid Sequences of Chitotriosidases-The sequence of 
the first 22 N-terminal amino acids of the 39-kDa protein with 
pi 8.0 is presented in Fig. 2. In the fraction containing chito-
triosidase activity with pi of about 7 .2, only the 50-kDa protein 
could be sequenced. The first 22 amino acids at theN terminus 
of this protein were identical to those at the N terminus of the 
39-kDa (pi 8.0) protein. Digestion of the purified 39-kDa chi-
totriosidase with trypsin resulted in a characteristic pattern of 
fragments. An internal sequence of 21 amino acids was ob-
tained from a digestion fragment of 30-kDa protein. 
Homology was proven to exist between theN-terminal and 
internal sequences of the human chitotriosidase and those of 
proteins that are members of a recently recognized chitinase 
protein family (14), as shown in Fig. 2. This family consists of 
proteins from various organisms, with strong homology in sev-
eral domains including the region that is involved in the catal-
ysis of the hydrolysis of chitin and the artificial substrate 
4MU-chitotrioside (15). 
Chitotriosidase Isozymes-Besides the two predominant 
forms of chitotriosidase with pi 7.2 and 8.0, isoelectric focusing 
of several Gaucher spleen extracts revealed minor forms of pi 
5.5-6.0 and pi about 6.5 (Fig. 3A). The apparent isoelectric 
point of chitotriosidase activity in Gaucher plasma was pre-
dominantly 7.2, with minor amounts of 6.0 and 8.0 (Fig. 3B). 
The isoelectric focusing profiles of chitotriosidase in corre-
sponding control materials were comparable (not shown). 
To study the relationship between the various chitotriosi-
dase isozymes, an antiserum was raised in a rabbit against 
purified native 39-kDa enzyme. This antibody recognized only 
native chitotriosidase, and more than 98% of the chitotriosi-
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TABLE I 
Isolation of pi 8.0 chitotriosidase from spleen of a type I Gaucher patient 
Data from a typical isolation are presented. Four independent isolations gave comparable results. 
Fraction 
Detergent-free extract 
PBE chromatofocusing 
Sephadex G-100 gel 
filtration 
Preparative IEF 
Volume 
ml 
110 
77 
28.5 
1.8 
FIG. 2. N-terminal amino acid se-
quence and an internal amino acid 
sequence of chitotriosidase; align-
ment with members of the chitinase 
protein family. The N-terminal se-
quence was determined for both the 39-
and 50-kDa isoforms of chitotriosidase 
and proved to be identical. The internal 
sequence was obtained from a tryptic 
fragment of the 39-kDa isoform of chito-
triosidase. The proteins are: HC gp-39, a 
human glycoprotein produced by chondro-
cytes and synovial cells (GenBank 
M80927); a bovine oviduct-specific glyco-
protein (GenBank D16639); a protein se-
creted in bovine whey during involution 
(SwissProt P30922; only the N-terminal 
amino acid sequence of this protein is 
available); YM-1, a secretory protein 
of activated mouse macrophages (Pir 
827879); an endochitinase of the nema-
tode B. malayi (SwissProt P29030); a 
chitinase of the hornworm Manduca sexta 
(GenBank U02270); and a chitinase of the 
fungus A. album (SwissProt P32470). 
Residues identical to chitotriosidase are 
indicated by white letters; capital letters 
indicate residues with similar properties 
to those in chitotriosidase. 
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Bovine glycoprotein 
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Murine YM-1 
B. malayi chitinase 
M. sexta chitinase 
A. album chitinase 
Internal sequence 
Specific activity 
nmol I mg·h- 1 
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37,220 
72,155 
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% -fold 
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FIG. 3. Isoelectric focusing profiles 
of chitotriosidase activity in Gaucher 
materials. Isoelectric focusing was per-
formed as described under "Materials and 
Methods." Chitotriosidase activity was 
measured with the 4MU-chitotrioside 
substrate. A, Gaucher spleen extract; B, 
Gaucher plasma sample. 
dase activity in the Gaucher spleen extract was immunopre-
cipitable with this immobilized anti-(39-kDa chitotriosidase) 
antiserum. Chitotriosidase in pi 8.0, 7.2, and 5.5-6.0 fractions 
was identically precipitated in immunotitration experiments 
(not shown). 
inherited defect. These observations suggest that the different 
chitotriosidase isozymes are most likely encoded by a single 
gene. 
All lysosomal hydrolases, with the exception of lysozyme, 
contain N-linked glycans that bind strongly to either the lectin 
concanavalin A or the lectin Ricinus communis agglutinin. 
When tested, chitotriosidase showed no affinity for binding to 
these two lectins (not shown). Incubation of pure 39-kDa chi-
totriosidase with endoglycosidases H and F or N-glycanase also 
did not result in a change in apparent molecular mass. Fur-
Earlier we found that some individuals are deficient in 
plasma chitotriosidase activity (9). We observed that a defi-
ciency in plasma was accompanied by a deficiency in other 
materials, such as spleen. The deficiency was not due to the 
presence of some inhibitor but probably the result of some 
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TABLE II 
Hydrolysis of substrates by human chitotriosidases, human lysozyme, and bacterial chitinase 
Chitinase activity was detennined with chitin azure as substrate; lysozyme activity was detennined with the M. lysodeikticus cell wall 
suspension assay. Assays were performed as described under "Materials and Methods." The lysozyme had been purified from human milk and the 
chitinase from S. marcescens. ND, not detennined. 
4MU- 4MU- Chitinase Enzyme chitobioside chitotrioside activity 
nmol I ml·h - 1 A 550 /ml·h- 1 
pi 8.0 chitotriosidase 25,904 33,371 52.1 
pi 7.2 chitotriosidase 13,928 20,020 45.8 
Human lysozyme 0 6 20.8 
Bacterial chitinase 123,100 118,000 306.9 
thermore, preliminary results of metabolic labeling experi-
ments with cultured macrophages revealed no shift in mobility 
upon addition to the culture medium of tunicamycin 
(not shown), again suggesting the absence of N-linked 
glycosylation. 
Hydrolysis of Substrates-The results of experiments on the 
substrate specificity of chitotriosidase are shown in Table 11. 
Purified samples of different pi forms showed a higher activity 
toward 4MU-chitotrioside substrate than toward 4MU-chito-
bioside, the ratio of chitobioside/chitotrioside activity of all 
chitotriosidase preparations being about 0.7. Both PNP-chito-
bioside and PNP-chitotrioside were hydrolyzed by purified chi-
totriosidase. However, in the case of the PNP-substrates the 
chitobioside substrate was more rapidly hydrolyzed. 
Since 4MU-chitotrioside has been reported to be a substrate 
for lysozyme (16), the activity was studied of purified chitotrio-
sidase toward a suspension of cell walls of M. lysodeikticus, a 
natural substrate for lysozyme. Purified chitotriosidase showed 
no lysozyme activity, as shown in Table 11. 
Because of the high degree of homology of chitotriosidase 
with a number of chitinases, it was of interest to study the 
capacity of chitotriosidase to degrade chitin, a polymer of /3-1,4-
linked N-acetylglucosamine moieties. Chi tin azure was used as 
substrate. Table 11 shows that chitin azure was, indeed, a 
substrate for this enzyme. When related to the hydrolysis of 
4MU-chitotrioside, degradation of chitin azure by the human 
chitotriosidase was even better than by the bacterial chitinase 
studied. 
DISCUSSION 
In this report we describe the purification and partial char-
acterization of the newly discovered human chitotriosidase 
that is highly elevated in Gaucher patients (9). The chitotrio-
sidase characterized by us may be identical to a human plasma 
4-methy I umbelliferyl-tetra -N -acety lchi totetraose hydrolase 
described by Den Tandt and eo-workers (17, 18). These inves-
tigators found that their partially purified enzyme did not 
exhibit hyaluronidase, neutral endoglucosaminidase, aspartyl-
glucosaminidase, /3-hexosaminidase, /3-glucosidase, or chitobi-
ase activity. We, too, were unable to demonstrate any /3-hex-
osaminidase or /3-glucosidase activity for the purified 
chitotriosidase. Nor was the enzyme able to hydrolyze the 
f3-l-4linkage between N-acetylglucosamine and muramic acid 
in cell walls from M. lysodeikticus, and thus it clearly differs 
from lysozyme. The relatively high enzymatic activity toward 
chitin suggests that our human chitotriosidase may be consid-
ered to be a functional chitinase. Indeed, sequencing of the N 
terminus and a digestion fragment of purified human chitotrio-
sidase revealed that this protein shares homology with chiti-
nases from non-mammalian organisms, e.g. the nematode Bru-
gia malayi (19) or the fungus Aphanocladium album (20). 
We noted that the human chitotriosidase was still active at 
50 oc and could be inhibited by Ag+. Similar properties have 
been documented for the chitinase (Ch1) of A. album (see Ref. 
Lysozyme PNP- PNP- Bio/trio ratio 
activity chitobioside chitotrioside 4-MU PNP 
units nmol/mz.h 1 
0 838.7 216.1 0.8 3.9 
ND 541.1 178.2 0.7 3.0 
2140 0.7 4.7 0.1 
2 19,532.3 21,725.8 1.0 0.9 
21, and references therein). 
Our finding that chitotriosidase is a chitinase is of particular 
importance since, even in recent publications (see e.g. Ref. 22), 
the human body is still believed to contain no chitin. 
Recently it has been recognized that not only do chitinases 
from various non-mammalian organisms (such as bacteria, 
fungi, plants, and insects) share structural homology but pro-
teins with a partially similar structure also occur in mammals. 
The members of the so-called chitinase protein family (14) 
differ in ability to catalyze the hydrolysis of chitin or chitin-like 
substrates such as 4-methylumbelliferyl chitotrioside. All doc-
umented mammalian members of the family have been found, 
so far, to be without chitinolytic activity. These mammalian 
proteins include a human cartilage protein (HC gp-39) (14, 23), 
a murine protein secreted by activated macrophages (YM-1; 
only documented in the Pir data bank), a bovine whey protein 
(24), as well as a baboon (25) and a bovine oviduct-specific 
glycoprotein (26). Their inability to hydrolyze substrate is most 
likely explained by the absence of critical acidic amino acids in 
the catalytic site region (15), as can be deduced from the nu-
cleotide sequence of cDNA encoding HC gp-39, YM-1, and bo-
vine oviduct-specific glycoprotein. The chitotriosidase isolated 
from Gaucher spleen clearly differed from the other mamma-
lian members of the chitinase protein family. This protein 
appears to be more closely related to the chitinases of non-
mammalian organisms, since it is also a functional chitinolytic 
enzyme. 
The human chitotriosidase described here may be involved in 
defense against and in degradation of chitin-containing patho-
gens such as fungi, nematodes, and insects. The function of the 
members of the chitinase protein family without chitinase ac-
tivity is unknown. Some, such as HC gp-39 and the bovine 
whey protein, are expressed in association with remodeling 
events (14). Interestingly, in plants, chitinases are believed to 
be involved in defense against pathogens as well as morphoge-
netic processes that involve remodeling (see Ref. 21, and refer-
ences therein). The role of the chitinases in morphogenesis is 
poorly understood since plants do not contain endogenous 
chitin. It cannot be excluded that, in analogy to the situation in 
plants, chitotriosidase in man also fulfills multiple functions. 
The relationship of the various chitotriosidase isozymes that 
occur in man is not precisely understood. However, the finding 
that all chitotriosidase activity is absent in some individuals (9) 
suggests that this enzyme is encoded by a single gene. This 
suggestion is in agreement with our present finding that an 
antibody raised against the 39-kDa chitotriosidase precipitated 
all isozymes. Moreover, the N terminus of at least the 39- and 
50-kDa isozymes was identical. The heterogeneity in chitotrio-
sidase could therefore be due to alternative splicing, post-trans-
lational proteolytic processing, or differences in glycosylation. 
Further information about the structure, the regulation of 
synthesis, and the routing of human chitotriosidase as well as 
its physiological substrate is required in order to be able to 
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understand the role of the enzyme under normal and patholog-
ical conditions. Cloning of the corresponding cDNA and analy-
sis of the processing of the protein are, therefore, being under-
taken. These investigations will be crucial to the identification 
of possible effects of the relatively common deficiency in en-
zyme activity in man (9) and to identify the cause and conse-
quences of the strong increase in plasma levels of chitotriosi-
dase in clinically affected Gaucher patients. 
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